Vaccine News and Research

Latest Vaccine News and Research

CZI, CZ Biohub, and The State Of California join forces to track COVID-19 transmission

Today, the Chan Zuckerberg Biohub, in partnership with the Chan Zuckerberg Initiative, announced that it will provide free whole genome sequencing and analysis of the SARS-CoV-2 virus to all California Departments of Public Health and California local health jurisdictions through a newly-launched effort called the California COVID Tracker.

30 Jul 2020

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.

30 Jul 2020

KHN’s ‘What the Health?’: Republicans in COVID disarray

President Donald Trump's pivot to a more serious view of the coronavirus pandemic didn't last long. This week, he was again touting hydroxychloroquine, an antimalarial drug that has not been shown to work against the virus.

30 Jul 2020

Medi-Cal agency’s new head wants to tackle disparities and racism

When Will Lightbourne looked at the statistics behind California's coronavirus cases, the disparities were "blindingly clear": Blacks and Latinos are dying at higher rates than most other Californians.

30 Jul 2020

Investigational vaccine and immune therapy work well together to fight breast cancer

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research.

30 Jul 2020

Updated cervical cancer screening guideline calls for less and more simplified screening

An updated cervical cancer screening guideline from the American Cancer Society reflects the rapidly changing landscape of cervical cancer prevention in the United States, calling for less and more simplified screening. The guideline appears in the ACS's flagship journal, CA: A Cancer Journal for Clinicians.

30 Jul 2020

UEA researchers examine flu vaccine uptake to learn lessons for COVID-19 immunization

Researchers at the University of East Anglia (UEA) are investigating uptake of the flu vaccine among care home staff in a bid to see if lessons can be learned to encourage people to have a COVID-19 immunisation.

30 Jul 2020

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.

30 Jul 2020

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.

30 Jul 2020

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

29 Jul 2020

Non-White adults are more likely to worry about paying for COVID-19 treatment

People of color are far more likely to worry about their ability to pay for healthcare if diagnosed with COVID-19 than their White counterparts, according to a new survey from nonprofit West Health and Gallup.

29 Jul 2020

Public health experts fear a hasty FDA signoff on vaccine

The vaccine trial that Vice President Mike Pence kicked off in Miami on Monday gives the United States the tiniest chance of being ready to vaccinate millions of Americans just before Election Day.

29 Jul 2020

Recurrent SARS-CoV-2 positives not infectious in discharged COVID-19 patients, says Chinese study

A new research paper from China published on the preprint server medRxiv* claims that recurrent positive results for SARS-CoV-2 are due to the presence of low levels of viral RNA fragments and not the shedding of infectious virus particles.

29 Jul 2020

Exciting cost-effective SARS-CoV-2 vaccine candidate using Newcastle disease

Experts warn that the world may see repeated waves of the COVID-19 pandemic. However, scientists around the world are working hard to create a protective vaccine or antiviral, which could help to reduce the number of deaths and cases the next time around.

29 Jul 2020

Emergent SARS-CoV-2 D614G spike mutation more infective due to "open" morphology

Researchers from the Los Alamos National Laboratory and Duke Human Vaccine Institute & Department of Surgery demonstrated that globally prevalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the amino acid substitution D614G in the spike protein is much more infective due to profitable binding encounters with the host receptors.

28 Jul 2020

Experimental vaccine rapidly controls coronavirus in the upper and lower airways of nonhuman primates

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19.

28 Jul 2020

Researchers unlock new insights that may help inform vaccine design for infectious diseases

Vaccination is the most effective public health measure to prevent infectious diseases. Vaccines can greatly reduce the risk of infection by working with the body's natural defenses to safely develop immunity to disease.

28 Jul 2020

Iron deficiency during infancy may reduce protective effect of vaccines

Despite the fact that global immunization programmes are now reaching more people than ever, about 1.5 million children still die every year from diseases that vaccination could have prevented. Vaccination is also less effective in low-income countries than in high-income countries, although it is not yet clear why.

28 Jul 2020

Experts provide a comprehensive view of snakebite cases in the Middle East

Snakebite envenoming is a common problem in many parts of the world, but little is known about its magnitude in the Arab countries of the Middle East, where cases are not widely reported.

28 Jul 2020

Researchers identify practical way to induce strong and broad immunity to dengue virus

Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have found a practical way to induce a strong and broad immunity to the dengue virus based on proof-of-concept studies in mice.

28 Jul 2020

Vaccine News and Research

Latest Vaccine News and Research

CZI, CZ Biohub, and The State Of California join forces to track COVID-19 transmission

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

KHN’s ‘What the Health?’: Republicans in COVID disarray

Medi-Cal agency’s new head wants to tackle disparities and racism

Investigational vaccine and immune therapy work well together to fight breast cancer

Updated cervical cancer screening guideline calls for less and more simplified screening

UEA researchers examine flu vaccine uptake to learn lessons for COVID-19 immunization

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Non-White adults are more likely to worry about paying for COVID-19 treatment

Public health experts fear a hasty FDA signoff on vaccine

Recurrent SARS-CoV-2 positives not infectious in discharged COVID-19 patients, says Chinese study

Exciting cost-effective SARS-CoV-2 vaccine candidate using Newcastle disease

Emergent SARS-CoV-2 D614G spike mutation more infective due to "open" morphology

Experimental vaccine rapidly controls coronavirus in the upper and lower airways of nonhuman primates

Researchers unlock new insights that may help inform vaccine design for infectious diseases

Iron deficiency during infancy may reduce protective effect of vaccines

Experts provide a comprehensive view of snakebite cases in the Middle East

Researchers identify practical way to induce strong and broad immunity to dengue virus

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in